VEGFD and lymphangioleiomyomatosis: Young et al. first described the utility of VEGF-D for diagnosing LAM in women with typical cystic change on High-Resolution Computed Tomography (HRCT) [5, 6] and the diagnostic performance of the test has since been validated in several LAM cohorts [7–10].